Positron emission tomography (PET) using the tracer [18F]-fluorodeoxyglucose (FDG) is commonly used for measuring metabolic rate of glucose (MR glc ) in the human brain. Conventional PET methods (e.g., the Patlak method) for quantifying MR glc assume the tissue transport and phosphorylation mechanisms to be in steady state during FDG uptake. As FDG and glucose use the same transporters and phosphorylation enzymes, changing blood glucose levels can change the rates of FDG transport and phosphorylation. Compartmental models were used to simulate the effect of rising arterial glucose, from normal to hyperglycemic levels on FDG uptake for a typical PET protocol. The subsequent errors on the values of MR glc calculated using the Patlak method were investigated, and a correction scheme based on measured arterial glucose concentration (G p ) was evaluated. Typically, with a 40% rise in G p over the duration of the PET study, the true MR glc varied by only 1%; however, the Patlak method overestimated MR glc by 15%. The application of the correction reduced this error to B2%. In general, the application of the correction resulted in values of MR glc consistently significantly closer to the true steady state calculation of MR glc independently of changes to the parameters defining the model.
Introduction
Measurements of cerebral metabolic rate of glucose (MR glc ) can be made in vivo using the fluorine-18 labeled tracer, fluorodeoxyglucose (FDG) in positron emission tomography (PET) as an indicator of brain metabolism. A standard method of quantifying MR glc is the graphical analysis technique by Patlak et al (1983) , commonly known as the Patlak plot. Briefly, this method requires the measurement of regional FDG uptake over time, a measure of FDG activity in the blood plasma (e.g., from continuous arterial sampling) and a measurement of the plasma glucose concentration. The plasma glucose concentration is assumed constant throughout the duration of the scan.
In experimental protocols investigating brain metabolism it may be difficult or impossible to maintain a constant plasma glucose level for the duration of the PET acquisition. For example, studies published by the authors have used methods in which the subject's glucose level is maintained at a constant level through the uptake period using a steady rate insulin infusion and a variable rate glucose infusion (e.g., Cranston et al, 2001; Bingham et al, 2005) . However, Anthony et al (2006) used a study protocol in which an insulin infusion was not available in half of the studies, and 6 of 14 subjects showed changes in plasma glucose levels over 1 mmol/L during the 90-min PET scan. The largest change was in a subject whose glucose levels rose from 6 mmol/L to a maximum of 8 mmol/L.
The purpose of this study was to estimate the effect of changing plasma glucose levels on values of MR glc calculated using the Patlak method, and to establish a method of correcting for any such errors. FDG-PET is considered the most robust noninvasive method of evaluating MR glc and no parallel in vivo techniques exist for measuring regional MR glc , which could accurately compare FDG-PET methods to actual glucose metabolism. For this reason, a simulation of FDG uptake was developed based on standard models of glucose transport and phosphorylation.
The calculations of glucose transport rates across the blood-brain barrier and phosphorylation rates in the tissue are derived from the three compartment model of FDG uptake developed by Sokoloff et al (1977) and Huang et al (1980) . This model requires the steady state uptake of tracer into the tissue, in which the transport and phosphorylation rates of FDG are constant for the duration of the measurements.
One way this condition can be violated without direct neuronal stimulation is if the blood glucose level changes. Both glucose transport across cell membranes and phosphorylation are saturable processes (Lund-Andersen, 1979) , therefore, a change in glucose level can change the number of available glucose transporters or hexokinase binding sites for FDG and consequently the observed uptake.
The main assumption underlying this study is that a rise in plasma glucose does not trigger an increase in MR glc . It is well known that hypoglycemia can trigger counterregulatory responses that are associated with changes in cerebral neuronal activation (Rizza et al, 1979 and Mitrakou et al, 1991) . Cerebral glucose oxidation in healthy subjects, calculated using [1-11 C]-D-glucose has been shown to increase significantly during hyperglycemia; however, these were at plasma glucose levels of 13.8 mmol/L (Blomqvist et al, 1998) . There are no reported studies of the effects of mild hyperglycemia on cerebral glucose metabolism in healthy subjects, with plasma glucose levels similar to those found in the study by Anthony et al (2006) .
Materials and methods

Models for Simulation of Glucose Kinetics
The compartmental model used to simulate glucose kinetics is shown in Figure 1 . Both glucose transport and phosphorylation can be described by Michaelis-Menten kinetics (Sokoloff et al, 1977) and so, in general terms, the rate of glucose transfer from compartments A to B is given by the equation,
where K is the transport rate 'constant' between compartments A and B (e.g., K 1 , k 2 , or k 3 ). V max is a constant defining the maximal transport rate, K t is the halfsaturation constant (equal to the concentration of glucose at which the rate is half V max ), and G A is the glucose concentration in compartment A. As typical plasma FDG concentrations are negligible compared with plasma glucose, the rate constants of both glucose and FDG kinetics can be considered independent of FDG concentrations.
On the basis of equation 1 we developed a computer simulation to describe the evolution of the rate constants K 1 , k 2 , and k 3 , and the intracellular glucose concentration, G i , over time in response to a continuous change in the plasma glucose concentration, G p . If G p is changing over time then K 1À3 and G i are also time dependent, and the rate 'constants' K 1À3 in Figure 1 are now given by
The superscripts in V max j (j = 1, 2, 3) refer to the maximal rates of transfer relating to the different rate constants. The rate of change of G i (t) is given by
The actual metabolic rate of the model, MR act , is given by
Fluorodeoxyglucose Kinetics
The same three-compartment model shown in Figure 1 was used to simulate FDG uptake, in which the time-dependent G i , G p , and K 1À3 are provided by the glucose simulations above. A typical uptake curve, F T , from a dynamic FDG-PET brain study in a volume of interest (VOI) in the brain comprises unphosphorylated FDG in tissue, F i , FDG-6-P in tissue, F m , and a small fraction, b, of FDG in blood, F b , assumed to be equal to the arterial FDG sample. The total FDG uptake is then given by
where F i and F m are the FDG concentrations in the compartments and are denoted as C i and C m , respectively, in Figure 1 .
Patlak for the Steady State Model
The Patlak method assumes that, under steady state conditions in which the transfer rate parameters K 1 , k 2 , and k 3 are constant, after a time, t', F i equilibrates with the concentration of FDG in the plasma, F p . Therefore, when t > t', MR glc is related to a 'grouped' transfer rate constant, Figure 1 Three-compartment model by Sokoloff et al (1977) for glucose/FDG kinetics in the brain. The compartments, C p , C i , and C m , are the concentrations of glucose/FDG in the plasma, in the cell, and as phosphorylated substrate (i.e., Glucose-6-P or FDG-6-P), respectively. Arrows with solid lines represent routes of transfer between the compartments available to both glucose and FDG. The dotted line shows the route of further glycolysis available to glucose only. K i , (see Figure 2 ) and the equation used to derive it is given by
A plot of F T (t)/F p (t) against F p (t)dt/F p (t) should reveal a straight line with gradient K i and intercept Z for t > t'. So MR glc is given by
where G p is the plasma glucose concentration and LC is the lumped constant derived by Sokoloff et al (1977) . As the values of LC are not of primary concern for this study, the value will be assumed to be 1 except where stated otherwise.
Glucose Corrected Patlak Method
According to the published values of K m , K t , and G i (e.g., Lund-Andersen 1979 and Barros et al, 2007) in healthy human brain cells under typical conditions, hexokinase is highly saturated, whereas values of K t are of the same order of G p and G i . To avoid using highly variable published values of K m and K t in any correction method, this modified equation assumes that the transfer system as shown in Figure 2 is completely saturated. Therefore, with changing G p a grouped transfer rate constant, K i ', that is equivalent to K i had G p not changed (i.e., from its value at t = 0) can be calculated from
and MR glc is given by
We investigated how well this corrected method can calculate MR glc compared with no correction in the face of changing plasma glucose levels. MR glc calculated from the uncorrected and corrected methods will be denoted as MR unc and MR cor , respectively. For situations in which G p was changing, MR unc was calculated using the mean value of G p between t start and t end , that is,
Under steady state conditions, MR unc and MR cor are equal and will be denoted as MR ss .
Simulations
Plasma Glucose and Initial Kinetic Parameters
Six plasma glucose profiles were simulated as a linear rises from 5 mmol/L up to 5 (i.e., steady state), 7, 9, 11, 13, and 15 mmol/L over 2 h. These profiles were denoted as GP1, GP2, GP3, GP4, GP5, and GP6, respectively. Time dependent K 1À3 , G i , and MR act were calculated for each plasma glucose profile with a range of initial values. K 1 (t = 0) was set to 0.001 ml g À1 s À1 and a range of initial values of k 2 and k 3 were chosen; 0.0006 to 0.002 s À1 and 0.0001 to 0.0016 s À1 , respectively. Initial values of G i were calculated from the initial values of G p and K 1À3 . This assumes that the system is in steady state before the rise.
The half-saturation constants used for transport and phosphorylation, K t and K m , respectively, were fixed at 4 and 0.05 mmol/L (typical values are presented in Barros et al, 2007 and Lund-Andersen 1979, respectively) . The constants V max j (j = 1 to 3) were calculated from K t , K m , and initial values of K 1À3 and G p .
Fluorodeoxyglucose Kinetics and Patlak
For each plasma glucose profile and set of timedependent kinetic parameters, a 2-h FDG time activity curve with 1-sec frames was simulated with b = 0.05 (equation 4) and a simulated arterial FDG curve, F p , as described by Feng et al (1993) . To investigate the effect of time on the Patlak calculation, a range of t end (15 to 120 mins) was used to calculate MR unc and MR cor , where t end _ t start = 300 s. The effect of the kinetics on the efficacy of both Patlak methods was assessed using the ratios MR unc / MR act and MR cor /MR act . The effect solely of the correction term was assessed using the ratios MR cor / MR ss , MR unc /MR ss , or MR unc /MR cor.
Kinetic Constants
The published values of K t and K m are variable so a range of values either side of published values (K t = 1 to 32 mmol/L and K m = 0.001 to 1.0 mmol/L) were also used in the simulation to assess the effect on the Patlak correction (i.e., MR cor /MR unc ).
The model of the LC presented in Crane et al (1983) is dependent on the values of k 2 , k 3 , and 'transport coefficient' and 'phosphorylation coefficient' denoted as TC and PC, respectively. TC is equal to the ratio of the transport rate constants of glucose and FDG and PC, the ratio of the phosphorylation rate constants of glucose and FDG. The effect of these parameters on the Patlak correction (i.e., MR cor / MR unc ) was investigated using a range of TC and PC (TC = 0.2 to 2.5 and PC = 0.1 to 1.0) around the published values (Kuwabara et al, 1990 ) of 1.1 and 0.3, respectively. Patlak et al (1983) representing free FDG concentration in the plasma, F p , and FDG-6-P concentration, F m .
Effect of rising glucose on FDG-PET quantification
Fluctuating G p and Fluorodeoxyglucose Noise Typical plasma glucose profiles are not linear so the effect of random fluctuations of G p was also investigated. Plasma glucose samples were simulated at 5-min intervals with fluctuations of the order of those observed in real studies. Profiles were simulated with normally distributed values around the mean calculated from the base linear glucose profiles (GP1-6) and a standard deviation (s.d.) of 0.15 mmol/ L (derived from profiles by Anthony et al, 2006, which showed no significant rising trend). The G p input to the glucose model was resampled to 1-sec intervals using a spline interpolation fitting the assumption that actual plasma glucose profiles vary smoothly. About 100 randomly fluctuating glucose profiles were generated to estimate the population mean and s.d. of MR cor and MR unc .
Noise arising in typical FDG-PET scans was also simulated using noise levels representing different dynamic frame durations and different size VOIs. Noise was calculated from the simulated uptake and variance parameters derived from a phantom study on a GE Discovery ST in 3D mode with CT attenuation correction and scatter correction. 100 noisy FDG uptake curves were simulated for a 2-h uptake period with 5 mins frame durations, for each glucose profile and for each noise function, representing a 1 voxel (2 Â 2 Â 3.27 mm) VOI and a 100 voxel VOI.
To simulate the effects of randomly fluctuating glucose profiles or noisy FDG uptake curves, the following initial parameters were used, K 1 = 0.001 ml g À1 s À1 , k 2 = 0.0012 s À1 , k 3 = 0.0008 s À1 , b = 0.05. Patlak calculations were made with t start = 30 mins and t end = 60 mins. These parameters are in the ranges of a typical FDG scan. 
Results
Plasma Glucose and Initial Kinetic Parameters
Example plots of simulated G p , G i , k 3 , and MR act are shown in the top two panels of Figure 3 . In nonsteady state simulations in which G p rose linearly, G i was approximately proportional to G p after a small period of equilibration between the two compartments. Values of k 3 fell almost inversely proportionally to the rise in G i resulting in MR act remaining approximately constant, showing only a very small rise with G p .
MR act rose by less than 2% over 120 mins in the most extreme cases, with the steepest rise in plasma glucose levels (GP6). The rise in MR act was mostly dependent on the G p profile and the initial value of k 3 . Small initial values of k 3 and large rises in G p provoked the largest change in MR act . Substituting typical values found in our insulin study (Anthony et al, 2006) into this simulation revealed MR act increases of around 0.5% over 120 mins. As values for MR act are very stable over time, a single value equal to the mean over 120 mins is used to compare with MR ss , MR unc , and MR cor.
Fluorodeoxyglucose Kinetics and Patlak
Under the steady state condition, the theoretical maximum ratio, from equation (4), of MR ss to MR act is 1-b, which would occur when the intracellular FDG concentration was in equilibrium with plasma FDG. Simulated uptake used b = 0.05, so the theoretical maximum of MR ss /MR act under steady state conditions was 0.95.
Steady state simulations showed MR ss /MR act ratio depended on values of k 2 and k 3 . The value of t start also affected this ratio. The higher values of k 2 and k 3 gave ratios closer to 0.95 as the time taken for F i and 
Intercellular glucose (FDG) concentration GP1, GP2, GP3, y Simulated rising plasma glucose profiles. GP1 simulates euglycemia at 5 mmol/L, and GP2, 3, 4, 5, and 6 simulate rises from 5 mmol/L to 7, 9, 11, 13, and 15 mmol/L over a 2-h period, respectively MR act Simulated actual metabolic rate (k3 Â Gi) MR unc Metabolic rate calculated using Patlak method, with no correction for rising plasma glucose (see equations (5) and (6)) MR cor Metabolic rate calculated using Patlak method, with correction for rising plasma glucose (see equations (7) and (8) Calculated from Monte Carlo simulations of noisy FDG-PET data for VOIs of 1 voxel and 100 voxels (voxel size, 2 Â 2 Â 3.27 mm) from a 3D scan with 5-min frames and linearly varying plasma glucose profiles (GP1-6). The initial parameters for the FDG uptake model were K 1 = 0.001 ml g À1 s À1 , k 2 = 0.0012 s À1 , k 3 = 0.0008 s À1 , and b = 0.05. MR ss is the metabolic rate calculated by the Patlak method at steady state with no noise added.
F p (equation 4) to equilibrate, t', is lower under these circumstances (see Figure 4 , top panel). Simulations with linearly increasing G p revealed the effect of the correction. Figure 4 , middle panel, shows MR unc /MR act highly dependent on t end , whereas MR cor /MR act (Figure 4, bottom panel) is much more stable for all except very low initial values (t = 0) of k 3 or t end and then not much different to the dependence to either of these parameters under steady state conditions (i.e., compared with Figure 4 , top panel). Figure 5 shows the effect of the correction on rising glucose profiles for parameters in the range of a typical FDG scan protocol (K 1 (t = 0) = 0.001 ml g À1 s À1 , k 2 (t = 0) = 0.0012 s À1 , b = 0.05, t start = 30 mins and t end = 60 mins). Across the range of k 3 (t = 0), MR unc / MR act values show a wide spread of values between GP1 and GP6. The correction brings these values closer to those from GP1. For example, with an initial value of k 3 = 0.0008 s À1 with GP3, MR unc /MR ss = 1.149 and MR cor /MR ss = 1.023.
Kinetic Constants
For rising glucose profiles, MR cor /MR act changed with respect to K t and K m ; however, the effect of the correction was virtually constant within each glucose profile. For example, the ratio MR cor /MR unc was 0.775 (3 d.p.) for all values of K t and K m with GP6 (the most extreme case of rising plasma glucose) with a difference of 0.00022 between the maximum and minimum.
For varying TC and PC, across the range of K 1À3 , the MR cor /MR unc ratio for GP6 had negligible variance (minimum, 0.7769; maximum, 0.7784).
Fluctuating G p and Fluorodeoxyglucose Noise
The MR cor /MR unc ratios for linearly rising glucose for these parameters were 1.0 (exactly), 0.941, 0.890, 0.847, 0.810, and 0.777 for GP1-6, respectively. Fluctuating glucose profiles also had negligible effect on the accuracy of the correction factor. For profiles based on GP1, the mean ± s.d. of the ratio MR cor /MR unc was 1.000±0.008; GP2, 0.940±0.008; GP3, 0.890±0.007; GP4, 0.848±0.006; GP5, 0.809 ± 0.006; and GP6, 0.778 ± 0.005. That is, all estimated means are comparable with the values calculated without these fluctuations, with s.d. < 1%.
Adding noise to the simulated FDG uptake also had negligible effect on the MR cor /MR unc ratio. In all cases MR cor < MR unc . For a VOI of 1 voxel the mean ± s.d. of the ratio MR cor /MR unc for GP2 was 0.940±0.001; GP3, 0.891±0.002; GP4, 0.847±0.002; GP5, 0.810±0.003; and GP6, 0.777±0.003. For a VOI of 100 voxels: GP2, 0.940 ± 0.0004; GP3, 0.891 ± 0.0008; GP4, 0.847 ± 0.0010; GP5, 0.810 ± 0.0014; and GP6, 0.777±0.0015. That is, all estimated means are comparable with the values calculated without PET noise. Table 2 shows similar data but of the ratios of MR cor or MR unc to the steady state Patlak calculation with the same parameters but no noise (equal to 0.927 Â MR act ). The differences in the standard deviations indicate that for large VOIs, the correction is important but might not be so important for smaller VOIs.
Discussion
FDG uptake in brain was simulated during nonsteady state conditions to investigate the validity of a proposed correction to the calculated MR glc using the Patlak method. Rising arterial glucose concentrations were simulated from normal to hyperglycemic levels (5 mmol/l and higher).
In all cases, the correction method improved on the standard Patlak method. It is important to establish the meaning of 'improve' in this context. The Patlak method is used in FDG-PET studies to provide a simplified calculation of MR glc . However, the assumptions on which this method is based mean that incomplete equilibration of FDG concentration between plasma and tissue compartments, poorly defined values for the ratios of transfer rates between FDG and glucose and the assumption of negligible blood volume in the region of interest can result in deviations of the Patlak calculations from the actual metabolic rate, even under steady state conditions. Nevertheless, it is of interest to note that, in conditions where plasma glucose levels are changing but metabolic rate changes are negligible, how well the correction to the Patlak method recreates values that would be obtained under euglycemic conditions using the standard method. Where values of MR cor are closer to MR ss than MR unc , then this is considered an improvement.
MR cor and MR unc less accurately matched MR act in cases where initial values of k 2 and/or k 3 were small compared with K 1 , as FDG equilibrium between plasma and tissue would take longer to achieve. These values also affected the impact of t end on the Patlak calculations in all cases. For small initial values of k 2 and/or k 3 , the accuracy of the Patlak calculation in reproducing actual metabolic rates was greatly affected by the t end chosen. This effect Figure 4 Plots showing ratio of Patlak calculated MR to simulated actual MR (y-axis) against t end (x-axis), where t end -t start = 300 s. For all graphs K 1 = 0.001 ml g À1 s À1 , k 2 = 0.0012 s À1 , b = 0.05 and the different line series represent results using six different initial values of k 3 (see legend in top graph). Top graph shows results with a euglycemic glucose profile (GP1), where the y-axis is MR ss /MR act ; middle graph shows results with rising glucose profile, GP3, where the y-axis is MR unc /MR act ; bottom graph shows results with rising glucose profile, GP3, where the y-axis is MR cor /MR act. Figure 5 Plots showing ratio of Patlak calculated MR to simulated actual MR (y-axis) against initial values of k 3 (x-axis, s À1 ), where K 1 = 0.001 ml g À1 s À1 , k 2 = 0.0012 s À1 , and b = 0.05. Left plot shows MR unc /MR act , and the right plot shows MR cor /MR act . The different line series show results from different glucose profiles (filled black circles represent results from GP1, and white squares represent results using GP6). Patlak slope is calculated between t start = 1,800 and t end = 3,600 s. was greater at small values of t end . As can be seen in Figure 4 , calculations at small t end overestimate MR act and calculation made at later times under estimated it. The early values of t end for which the Patlak calculations equalled MR act differed depending on the values of k 2 and k 3 , so it would not be appropriate to use an early t end . It should be noted that the small initial values of k 2 and k 3 discussed here do not produce the characteristic FDG uptake curves observed in typical PET scans.
The values of parameters such as K t , K m , TC, and PC have been taken from earlier studies or assumed. The quoted values are either uncertain or cover a wide range so a single simulation may not accurately reflect this. However, a wide range of values used in the simulation did not change the effect of the Patlak correction significantly.
In studies where the Patlak method for determining MR glc is used, the LC is usually assumed to be constant or 1.0. We have addressed here a correction for changing plasma glucose levels that we have shown to be true if the assumption of constant LC holds. In practice, LC will change during the course of the study if G p diverges from euglycemia during this period. In this case, inaccuracies in Patlak calculation of MR glc will be due to both changes in G p directly and through changes in the LC. In this work, we only deal with the first of these effects.
There is no simple relationship between plasma glucose and LC and, in general, the value of LC depends on the values of the individual rate constants (K 1 , k 2 , k 3 ), and these are not available when data are acquired with a view to Patlak analysis. Changes in K i and LC due to increasing plasma glucose both result in an underestimation of MR glc if constant G p and LC are assumed in the analysis. Correcting for G p but neglecting LC changes will, therefore, still lead to an improved estimate of MR glc . A detailed evaluation of the residual error resulting from neglecting changes in LC warrants a more detailed analysis but is beyond the scope of this paper.
The model used to simulate glucose and FDG kinetics relied on the assumption that the enzyme, dephosphorylase, is present in negligible amounts. If this assumption was invalid then another parameter (usually denoted as k 4 ), which would allow transfer back from compartments C m to C i (see Figure 1 ) would need to be included to represent the dephosphorylation of glucose-6-phosphate. However, this would complicate the model, as the assumption allows C m to be ignored. Any model including k 4 would need a more sophisticated model of glucose kinetics including further metabolism of glucose from phosphorylation. Glucose-6-dephosphoryalse is reported to be present in small amounts in the human brain and studies of FDG kinetics have shown that including k 4 significantly improves the fit of the model to the data (e.g., Hasselbalch et al, 1999 , Schmidt et al, 1992 . These studies have shown the value of k 4 to be approximately 1/10th of k 3 , yielding a 30% difference in calculated metabolic rate. A more sophisticated glucose model would allow a more rigorous simulation of glucose metabolic rate and FDG kinetics under changing plasma glucose. The Patlak method assumes that k 4 is negligible and so the presence of dephosphorylase would mean the Patlak method would further underestimate glucose metabolism; however, this would apply to both the uncorrected Patlak and corrected Patlak calculations. This study has shown that although physiological parameters defining the model may be poorly defined (e.g., K t , TC, etc), the ratio of MR cor /MR unc is insensitive to these values.
The validity of this method is dependent on whether the change in the actual MR glc due to a rise in plasma glucose is negligible. This method assumes that the change in FDG uptake is due solely to the effect of competition for glucose transporters and hexokinase. Although this assumption was not implicit in the model, the low published values of K m suggest that phosphorylation of glucose is a highly saturated process. Even with a three-fold increase in plasma glucose (GP6), our model showed a very small increase in MR act over the 2-h period (B2%). It is unclear whether this assumption is valid for such high plasma glucose changes in the real world but for more moderate rises it may be more so.
In conclusion, the Patlak method has been shown to yield incorrect results with plasma glucose levels rising from normoglycemia to hyperglycemia during FDG-PET acquisition. Assuming that glucose metabolic rate does not change with moderate changes in plasma glucose levels, a corrected Patlak equation may be used to calculate more accurate rates. The method described above is straightforward to implement in practice. If there is a reason to suspect that plasma glucose levels are likely to change throughout an acquisition, then in addition to the standard protocol, plasma glucose levels are required throughout the scan (typically these would be measured at 5min intervals). These values are then substituted into equations 7 and 8 to calculate the corrected glucose metabolic rate.
